Clinical efficacy of efgartigimod combined with intravenous methylprednisolone in the acute phase of neuromyelitis optica spectrum disorders

Clinical efficacy of efgartigimod combined with intravenous methylprednisolone in the acute phase of neuromyelitis optica spectrum disorders

Abstract Background Neuromyelitis Optica Spectrum Disorders (NMOSD) comprise a group of autoimmune-mediated, inflammatory, demyelinating central nervous system diseases caused by aquaporin-4 (AQP4) IgG autoantibodies. Efgartigimod is a human IgG Fc fragment that reduces antibody titers by targeting...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenjing Yang, Pei Chen, Jiaxuan Guo, Huiyu Feng, Xin Huang
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Neuromyelitis optica spectrum disorders
Efgartigimod
Intravenous methylprednisolone
Treatment of acute phase
Online Access:https://doi.org/10.1186/s13023-024-03501-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13023-024-03501-6

Similar Items